AAPL   319.12 (+0.27%)
MSFT   181.92 (+0.29%)
FB   224.90 (-0.25%)
GOOGL   1,424.50 (+0.44%)
AMZN   2,408.50 (+0.31%)
NVDA   345.40 (+1.74%)
CGC   17.71 (-18.46%)
MU   47.41 (+2.02%)
TSLA   818.67 (+1.60%)
AMD   52.60 (+1.66%)
T   30.54 (-1.67%)
ACB   14.02 (-8.61%)
F   5.64 (-3.59%)
GILD   75.08 (-0.32%)
DIS   115.40 (-1.16%)
NFLX   413.82 (+0.09%)
BAC   24.41 (-1.81%)
BA   144.19 (-3.76%)
AAPL   319.12 (+0.27%)
MSFT   181.92 (+0.29%)
FB   224.90 (-0.25%)
GOOGL   1,424.50 (+0.44%)
AMZN   2,408.50 (+0.31%)
NVDA   345.40 (+1.74%)
CGC   17.71 (-18.46%)
MU   47.41 (+2.02%)
TSLA   818.67 (+1.60%)
AMD   52.60 (+1.66%)
T   30.54 (-1.67%)
ACB   14.02 (-8.61%)
F   5.64 (-3.59%)
GILD   75.08 (-0.32%)
DIS   115.40 (-1.16%)
NFLX   413.82 (+0.09%)
BAC   24.41 (-1.81%)
BA   144.19 (-3.76%)
AAPL   319.12 (+0.27%)
MSFT   181.92 (+0.29%)
FB   224.90 (-0.25%)
GOOGL   1,424.50 (+0.44%)
AMZN   2,408.50 (+0.31%)
NVDA   345.40 (+1.74%)
CGC   17.71 (-18.46%)
MU   47.41 (+2.02%)
TSLA   818.67 (+1.60%)
AMD   52.60 (+1.66%)
T   30.54 (-1.67%)
ACB   14.02 (-8.61%)
F   5.64 (-3.59%)
GILD   75.08 (-0.32%)
DIS   115.40 (-1.16%)
NFLX   413.82 (+0.09%)
BAC   24.41 (-1.81%)
BA   144.19 (-3.76%)
AAPL   319.12 (+0.27%)
MSFT   181.92 (+0.29%)
FB   224.90 (-0.25%)
GOOGL   1,424.50 (+0.44%)
AMZN   2,408.50 (+0.31%)
NVDA   345.40 (+1.74%)
CGC   17.71 (-18.46%)
MU   47.41 (+2.02%)
TSLA   818.67 (+1.60%)
AMD   52.60 (+1.66%)
T   30.54 (-1.67%)
ACB   14.02 (-8.61%)
F   5.64 (-3.59%)
GILD   75.08 (-0.32%)
DIS   115.40 (-1.16%)
NFLX   413.82 (+0.09%)
BAC   24.41 (-1.81%)
BA   144.19 (-3.76%)
Log in

NASDAQ:KALAKala Pharmaceuticals SEC Filings & 10K Form

$12.00
-0.25 (-2.04 %)
(As of 05/29/2020 01:20 PM ET)
Add
Compare
Today's Range
$11.94
Now: $12.00
$12.44
50-Day Range
$8.50
MA: $10.77
$13.09
52-Week Range
$3.24
Now: $12.00
$13.55
Volume23,299 shs
Average Volume1.03 million shs
Market Capitalization$654.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.26

SEC Filings

Kala Pharmaceuticals (NASDAQ:KALA) SEC Filings

DateFilerForm TypeView
05/26/2020
7:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
11:15 PM
Kala Pharmaceuticals (Filer)
Form EFFECT
05/07/2020
4:21 PM
Kala Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/07/2020
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
7:54 AM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/29/2020
7:50 AM
Kala Pharmaceuticals (Filer)
Form DEF 14A
04/13/2020
7:38 AM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2020
3:43 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
4:46 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
6:59 AM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:47 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:45 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:19 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
03/10/2020
8:26 PM
Kala Pharmaceuticals (Filer)
Form 424B5
03/10/2020
8:03 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2020
5:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
4:24 PM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
6:15 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
3:06 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:19 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
4:56 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
4:56 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:05 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:28 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:03 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:02 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:01 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
9:41 AM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:36 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:06 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:08 PM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/12/2019
3:02 PM
Kala Pharmaceuticals (Filer)
Form DEF 14A
03/12/2019
7:42 AM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2019
7:32 AM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
3:56 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
9:16 AM
Hadley Harbor Master Investors L.P. (0001641080) (Filed by)
Kala Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
8:57 AM
Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/07/2019
6:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
4:05 PM
Iwicki Mark T (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:04 PM
Brazzell Romulus K (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:03 PM
Bazemore Todd (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
4:02 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:07 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
3:01 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
8:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
3:19 PM
Kala Pharmaceuticals (Subject)
Longitude Capital Partners II, LLC (Filed by)
Form SC 13D
10/11/2018
3:11 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:46 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:34 PM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:33 PM
Kala Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:31 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
10/05/2018
5:01 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
10/02/2018
4:26 PM
Kala Pharmaceuticals (Filer)
Form 424B2
10/02/2018
3:40 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
3:38 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:30 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2018
11:15 PM
Kala Pharmaceuticals (Filer)
Form EFFECT
08/23/2018
4:00 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
12:41 PM
Kala Pharmaceuticals (Filer)
Form CT ORDER
08/20/2018
6:07 AM
Kala Pharmaceuticals (Filer)
Form S-3/A
08/15/2018
7:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
8:41 AM
Kala Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
08/09/2018
4:27 PM
Kala Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/09/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
6:10 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
9:51 AM
Kala Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
9:50 AM
Kala Pharmaceuticals (Issuer)
LANGER ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:57 PM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
3:47 PM
Kala Pharmaceuticals (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:47 PM
Grunberg Gregory (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:47 PM
Hill Paulina (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:46 PM
Kala Pharmaceuticals (Issuer)
Paull Robert Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:46 PM
Kala Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
6:05 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
3:07 PM
Kala Pharmaceuticals (Filer)
Form DEFA14A
04/25/2018
3:01 PM
Kala Pharmaceuticals (Filer)
Form DEF 14A
04/19/2018
9:24 AM
Kala Pharmaceuticals (Filer)
Form CT ORDER
04/09/2018
4:28 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2018
4:23 PM
Kala Pharmaceuticals (Issuer)
Trachtenberg Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2018
3:04 PM
Kala Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/02/2018
3:02 PM
Kala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2018
6:06 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2018
7:00 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
7:07 AM
Kala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2018
4:28 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:23 PM
Kala Pharmaceuticals (Issuer)
PERRY GREGORY D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/02/2018
4:19 PM
Chen Hongming (Reporting)
Kala Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
4:13 PM
Kala Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D
02/13/2018
3:10 PM
Kala Pharmaceuticals (Subject)
THIRD ROCK VENTURES LP (Filed by)
Form SC 13G
02/09/2018
3:29 PM
Kala Pharmaceuticals (Issuer)
LaRussa Michele (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2018
4:05 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2018
4:45 PM
Kala Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.